Mcrpc is prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Stromal Cells Neoplastic Cells, Circulating Cell Nucleus

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Adenoviridae

Diseases35

Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Neoplasm Metastasis Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Carcinoma Lung Neoplasms Neoplasm Recurrence, Local Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Prostatitis Pancreatic Neoplasms Neovascularization, Pathologic Urinary Bladder Neoplasms Colorectal Neoplasms Uterine Cervical Neoplasms Disease Models, Animal Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Erectile Dysfunction Radiation Injuries Endometrial Neoplasms

Chemicals and Drugs72

Prostate-Specific Antigen Androstenols Receptors, Androgen Androgens Phenylthiohydantoin Androgen Antagonists Taxoids Tumor Markers, Biological Antineoplastic Agents Tosyl Compounds Antineoplastic Agents, Hormonal Androgen Receptor Antagonists Neoplasm Proteins Anilides RNA, Messenger Dihydrotestosterone Finasteride Metribolone Flutamide RNA, Small Interfering Anticarcinogenic Agents Prednisone Cancer Vaccines Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors PTEN Phosphohydrolase DNA, Neoplasm Testosterone Congeners Antineoplastic Agents, Phytogenic Antigens, Neoplasm Testosterone 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Nitriles Proto-Oncogene Proteins c-akt Racemases and Epimerases RNA, Neoplasm Tumor Suppressor Protein p53 Transcription Factors Cholestenone 5 alpha-Reductase MicroRNAs Estramustine Leuprolide Tumor Suppressor Proteins Goserelin Receptor, erbB-2 Glutathione S-Transferase pi Receptors, Estrogen DNA-Binding Proteins Proto-Oncogene Proteins Enzyme Inhibitors Antibodies, Monoclonal Prostatic Secretory Proteins Androgen-Binding Protein Proto-Oncogene Proteins c-bcl-2 Kallikreins Steroid 17-alpha-Hydroxylase Paclitaxel DNA Primers Oncogene Proteins, Fusion Insulin-Like Growth Factor Binding Protein 3 Carotenoids Ki-67 Antigen Receptor, Epidermal Growth Factor Trans-Activators Nuclear Proteins Cadherins Selenium Protein-Serine-Threonine Kinases Diphosphonates Plant Extracts Protein Kinase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment75

Orchiectomy Prostatectomy Early Detection of Cancer Neoplasm Grading Neoplasm Staging Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Prognosis Digital Rectal Examination Risk Factors Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Transplantation, Heterologous Immunohistochemistry Blotting, Western Case-Control Studies Gene Expression Profiling Transurethral Resection of Prostate Risk Prospective Studies Follow-Up Studies Biopsy Survival Rate Risk Assessment Survival Analysis Retrospective Studies Sensitivity and Specificity Biopsy, Needle Odds Ratio Brachytherapy Incidence Cohort Studies Transfection Tumor Burden Oligonucleotide Array Sequence Analysis Combined Modality Therapy Tissue Array Analysis Disease-Free Survival Castration SEER Program Multivariate Analysis Registries Predictive Value of Tests Radiotherapy Polymerase Chain Reaction Nomograms Kaplan-Meier Estimate Drug Screening Assays, Antitumor Logistic Models Molecular Targeted Therapy Radiotherapy Dosage Radiotherapy, Conformal Reproducibility of Results Questionnaires Models, Biological Mass Screening Gene Knockdown Techniques Confidence Intervals Clinical Trials as Topic Immunoenzyme Techniques Flow Cytometry Disease Models, Animal Radiotherapy, Intensity-Modulated In Situ Hybridization, Fluorescence Radiotherapy Planning, Computer-Assisted ROC Curve Chemotherapy, Adjuvant Immunotherapy Real-Time Polymerase Chain Reaction Genetic Therapy Proportional Hazards Models Radiotherapy, Image-Guided Immunoblotting Drug Administration Schedule

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Cell Proliferation Apoptosis Genetic Predisposition to Disease Risk Signal Transduction Cell Growth Processes Down-Regulation Sensitivity and Specificity Genotype Cell Division Cell Survival Odds Ratio Cell Movement Transfection DNA Methylation Up-Regulation Promoter Regions, Genetic Cell Cycle Polymorphism, Genetic Time Factors Dose-Response Relationship, Drug Mutation Nomograms Gene Silencing Gene Fusion Genes, Tumor Suppressor RNA Interference Chromosomes, Human, Pair 8 Base Sequence Gene Expression Phosphorylation Diet Polymorphism, Single Nucleotide Alleles Transcription, Genetic Genes, Neoplasm Germ-Line Mutation Drug Synergism Phenotype Radiation Tolerance Oncogene Fusion Genes, BRCA1 Epithelial-Mesenchymal Transition Transcriptional Activation Enzyme Activation

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science10

Survival Rate Incidence SEER Program Registries Radiotherapy, Conformal Questionnaires Base Sequence Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care33

Treatment Outcome Risk Factors Watchful Waiting Case-Control Studies Risk Prospective Studies Follow-Up Studies Survival Rate Risk Assessment Survival Analysis Retrospective Studies Sensitivity and Specificity Odds Ratio Incidence Cohort Studies Disease-Free Survival National Cancer Institute (U.S.)SEER Program Multivariate Analysis Age Factors Registries Predictive Value of Tests Nomograms Kaplan-Meier Estimate Logistic Models Reproducibility of Results Questionnaires Mass Screening Confidence Intervals Clinical Trials as Topic ROC Curve Proportional Hazards Models Radiation Injuries

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Prostatic Neoplasms Prostate-Specific Antigen Orchiectomy Androstenols Prostatic Neoplasms, Castration-Resistant Receptors, Androgen Androgens Phenylthiohydantoin Cell Line, Tumor Androgen Antagonists Prostatectomy Neoplasm Metastasis Taxoids Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Neoplasms, Hormone-Dependent Early Detection of Cancer Tumor Markers, Biological Mice, Nude Adenocarcinoma Antineoplastic Agents Disease Progression Prostatic Intraepithelial Neoplasia Tosyl Compounds Bone Neoplasms Drug Resistance, Neoplasm Neoplasm Invasiveness Neoplasm Grading Neoplasm Staging Cell Proliferation Treatment Outcome Tumor Cells, Cultured Antineoplastic Agents, Hormonal Apoptosis Genetic Predisposition to Disease Androgen Receptor Antagonists Neoplasm Proteins Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Prognosis Digital Rectal Examination Anilides Risk Factors Watchful Waiting Antineoplastic Combined Chemotherapy Protocols RNA, Messenger Neoplasm Transplantation Dihydrotestosterone Finasteride Breast Neoplasms Transplantation, Heterologous Neoplasms Immunohistochemistry Blotting, Western Case-Control Studies Gene Expression Profiling Metribolone Transurethral Resection of Prostate Carcinoma Risk Lung Neoplasms Signal Transduction Cell Growth Processes Neoplasm Recurrence, Local Prospective Studies Follow-Up Studies Flutamide RNA, Small Interfering Ovarian Neoplasms Biopsy Survival Rate Risk Assessment Anticarcinogenic Agents Down-Regulation Survival Analysis Prednisone Retrospective Studies Sensitivity and Specificity Cancer Vaccines United States Genotype Glutamate Carboxypeptidase II Cell Division Cell Survival Colonic Neoplasms Biopsy, Needle Mice, SCID 5-alpha Reductase Inhibitors Odds Ratio PTEN Phosphohydrolase DNA, Neoplasm Brachytherapy Incidence Cell Movement Cohort Studies Transfection Stomach Neoplasms Tumor Burden Oligonucleotide Array Sequence Analysis

No FAQ available that match "mcrpc is prostate cancer"